Gaithersburg, Maryland
United States
30
2025-02-13
The entities that hold a legal rights for patent applications filed by inventor Baca Manuel:
Manuel Baca from Gaithersburg, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ANTIBODIES AGAINST G-CSFR AND USES THEREOF
#2 | 2022-03-24Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer
#3 | 2021-08-26CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#4 | 2021-08-19URICASE SEQUENCES AND METHODS OF TREATMENT
#5 | 2021-01-14Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein
#6 | 2019-02-21ANTIBODIES AGAINST G-CSFR AND USES THEREOF
#7 | 2019-02-14Uricase sequences and methods of treatment
#8 | 2018-09-13Uricase sequences and methods of treatment
#9 | 2017-12-28High affinity antibody antagonists of interleukin-13 receptor alpha 1
#10 | 2017-12-28ANTI-VEGF ANTIBODIES
#11 | 2017-11-16CD40L-Fc fusion polypeptides and methods of use thereof
#12 | 2017-08-10ANTIBODIES AGAINST G-CSFR AND USES THEREOF
#13 | 2016-12-15High affinity antibody antagonists of interleukin-13 receptor alpha 1
#14 | 2016-09-08ANTI-VEGF ANTIBODIES
#15 | 2016-02-04ANTIBODIES AGAINST G-CSFR AND USES THEREOF
#16 | 2015-04-09CD40L-specific TN3-derived scaffolds and methods of use thereof
#17 | 2015-01-22ANTI-VEGF ANTIBODIES
#18 | 2014-05-22Protein scaffolds
#19 | 2014-02-27High affinity antibody antagonists of interleukin-13 receptor alpha 1
#20 | 2013-04-18TRAIL R2-specific multimeric scaffolds
#21 | 2013-03-28FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS
#22 | 2013-03-07ANTI-VEGF ANTIBODIES
#23 | 2012-12-20Antibodies against G-CSFR and uses thereof
#24 | 2011-12-08IL-11 muteins
#25 | 2011-03-03Anti-IL-13Rα1 antibodies and their uses thereof
#26 | 2010-11-25Protein scaffolds
#27 | 2010-11-11High affinity antibody antagonists of interleukin-13 receptor alpha 1
#28 | 2009-08-13Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
#29 | 2009-07-30IL-11 muteins
#30 | 2008-07-10High affinity antibody antagonists of interleukin-13 receptor alpha 1
126852 ā